Journal:
:hepatitis monthly
0
rahim rahimi department of internal medicine, shiraz university of medical sciences, shiraz, ir iran
seyed younes hosseini gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran
mohammad reza fattahi gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran; gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran. tel/fax: +98-7116474263
masood sepehrimanesh gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran
alireza safarpour gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran
seyed ali malekhosseini transplant research center, shiraz university of medical sciences, shiraz, ir iran
conclusions although the patients carrying m204i mutation were more likely to show lack of responses to lam therapy, lam replacing by other nucleoside/tide analogs plus hbig maybe still effective in decreasing hepatitis b recurrence after liver transplantation. however, it is suggested that drug resistance test should be considered by clinicians during therapeutic management to avoid the follow...